HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
TuHURA Biosciences, Inc./NV
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.78+0.02 (+1.14%)
Close on Oct 19, 2026
- Market cap
- $113.86M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
14.1%
9M of 64M shares
Institutional holders
90
24 new, 21 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 6,060,608 | 9.10% | 13G (passive) | Dec 31, 2025 |
| Charles S. Theofilos, M.D | 2,506,321 | 5.90% | 13G (passive) | Oct 18, 2024 |
| Samir Patel | 2,466,377 | 5.80% | 13G (passive) | Oct 18, 2024 |
| Vijay Patel | 12,346,430 | 26.70% | 13D (active) | Oct 18, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HURA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 2,267,901 | 3.56% | $5.31M | +193,673 | 0.00% |
| Northern Trust Corp | 1,621,042 | 2.54% | $3.79M | +1,322,855 | 0.00% |
| BlackRock, Inc. | 690,088 | 1.08% | $1.61M | −1,760,168 | 0.00% |
| Geode Capital Management, LLC | 484,219 | 0.76% | $1.13M | −502,703 | 0.00% |
| Millennium Management LLC | 454,535 | 0.71% | $1.06M | New | 0.00% |
| Aqr Capital Management LLC | 424,600 | 0.67% | $993.56K | −182,568 | 0.00% |
| Vanguard Fiduciary Trust Co | 251,186 | 0.39% | $587.78K | −35,947 | 0.00% |
| Citadel Advisors LLC | 232,319 | 0.36% | $543.63K | New | 0.00% |
| State Street Corp | 188,404 | 0.30% | $440.87K | −324,509 | 0.00% |
| Jane Street Group, LLC | 163,891 | 0.26% | $383.51K | New | 0.00% |
| Apollon Wealth Management, LLC | 156,519 | 0.25% | $366.25K | −1,491 | 0.00% |
| Qube Research & Technologies Ltd | 145,595 | 0.23% | $340.69K | New | 0.00% |
| Morgan Stanley | 143,257 | 0.22% | $335.22K | +119,424 | 0.00% |
| Goldman Sachs Group Inc | 131,768 | 0.21% | $308.34K | +61,522 | 0.00% |
| Bank of New York Mellon Corp | 121,662 | 0.19% | $284.69K | −89,906 | 0.00% |
| XTX Topco Ltd | 100,424 | 0.16% | $234.99K | +88,911 | 0.00% |
| WealthShield Partners, LLC | 91,530 | 0.14% | $214.18K | – | 0.03% |
| Aster Capital Management (DIFC) Ltd | 89,690 | 0.14% | $209.88K | New | 0.04% |
| Captrust Financial Advisors | 88,373 | 0.14% | $206.79K | New | 0.00% |
| Cetera Investment Advisers | 61,620 | 0.10% | $144.19K | −78,624 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 90 | 9M | 14.1% | 24 / 15 | 33 / 21 | 3M | 4M |
| Q1 2026 | 90 | 10M | 14.9% | 31 / 37 | 9 / 5 | 6M | 0M |
| Q4 2025 | 65 | 6M | 10.1% | 7 / 27 | 14 / 12 | 1M | 0M |
| Q3 2025 | 70 | 6M | 9.6% | 25 / 16 | 11 / 5 | 1M | 1M |
| Q2 2025 | 50 | 6M | 10.0% | 28 / 13 | 1 / 4 | 3M | 0M |
| Q1 2025 | 27 | 4M | 5.7% | 4 / 9 | 5 / 4 | 2M | 0M |
| Q4 2024 | 27 | 2M | 3.4% | 27 / 0 | 0 / 0 | 2M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of HURA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,740,756 | 2.73% | $4.07M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 447,671 | 0.70% | $1.05M | 0.00% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 219,328 | 0.34% | $495.68K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 206,600 | 0.32% | $466.92K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 163,708 | 0.26% | $383.08K | 0.03% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 76,331 | 0.12% | $172.51K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 59,410 | 0.09% | $134.27K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 42,988 | 0.07% | $97.15K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Growth Index Fund | 40,006 | 0.06% | $90.41K | 0.01% | May 31, 2026 |
| Vanguard Balanced Index Fund | 29,949 | 0.05% | $70.08K | 0.00% | Jun 30, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 16,774 | 0.03% | $39.25K | 0.00% | Jun 30, 2026 |
| Small Cap Index Fund | 14,958 | 0.02% | $33.81K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 11,039 | 0.02% | $25.83K | 0.01% | Jun 30, 2026 |
| Bridge Builder Small/Mid Cap Growth Fund | 7,465 | 0.01% | $17.47K | 0.00% | Jun 30, 2026 |
| Victory Extended Market Index Fund | 5,613 | 0.01% | $12.18K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| James A. Bianco | Chief Executive Officer, Director | 2,173,307 | 3.41% | May 29, 2026 |
| Dan Dearborn | Chief Financial Officer | 0 | – | Jan 8, 2026 |
| Robert E. Hoffman | Director | 68,902 | 0.11% | Feb 17, 2026 |
| George K. Ng | Director | 0 | – | Feb 17, 2026 |
| Alan List | Director | 0 | – | Feb 17, 2026 |
| James S. J. Manuso | Director | 0 | – | Feb 17, 2026 |
| Craig Tendler | Director | 0 | – | Feb 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| James A. Bianco Chief Executive Officer, Director | May 28, 2026 | Gift | −150,000 | – | – | 2,173,307 |
| James A. Bianco Chief Executive Officer, Director | Oct 18, 2024 | Award | +2,323,307 | – | – | 2,323,307 |
| Robert E. Hoffman President, CEO, and CFO, Director | Jun 1, 2023 | Award | +59,800 | – | – | 68,902 |
| Dennis M. Brown Chief Scientific Officer | Jan 5, 2023 | Inheritance | +363 | – | – | 5,302 |
| Anthony Scott Praill Chief Financial Officer | Aug 1, 2022 | Award | +240,087 | – | – | 277,273 |
| Robert E. Hoffman President and CEO, Director | Aug 1, 2022 | Award | +400,145 | – | – | 455,145 |
| Dennis M. Brown Chief Scientific Officer | Aug 1, 2022 | Award | +240,087 | – | – | 246,905 |
| Robert E. Hoffman President and CEO, Director | Feb 15, 2022 | Buy | +55,000 | $0.47 | $25.85K | 55,000 |
| Anthony Scott Praill Chief Financial Officer | Dec 8, 2021 | Buy | +28,700 | $0.68 | $19.52K | 37,186 |
| Saiid Zarrabian Head of Strategic Partnerships, Director | Dec 7, 2021 | Buy | +38,109 | $0.64 | $24.39K | 55,500 |
| Saiid Zarrabian Head of Strategic Partnerships, Director | Dec 6, 2021 | Buy | +11,891 | $0.59 | $7.02K | 17,391 |
| Laura L. Johnson Director | Nov 22, 2021 | Buy | +3,000 | $0.74 | $2.22K | 3,000 |
| Anthony Scott Praill Chief Financial Officer | Apr 29, 2021 | Conversion | +938 | – | – | 8,486 |
| Anthony Scott Praill Chief Financial Officer | Apr 29, 2021 | Other | +8 | – | – | 7,548 |
| Dennis M. Brown Chief Scientific Officer | Apr 29, 2021 | Conversion | +750 | – | – | 6,818 |
| Dennis M. Brown Chief Scientific Officer | Apr 29, 2021 | Other | +6 | – | – | 6,068 |
| Robert Joseph Toth Jr Director | Apr 29, 2021 | Other | +3 | – | – | 1,241 |
| Robert Joseph Toth Jr Director | Apr 29, 2021 | Conversion | +325 | – | – | 1,566 |
| Robert Joseph Toth Jr Director | Mar 31, 2021 | Other | +8 | – | – | 1,238 |
| Dennis M. Brown Chief Scientific Officer | Mar 31, 2021 | Other | +17 | – | – | 6,062 |
| Anthony Scott Praill Chief Financial Officer | Mar 31, 2021 | Other | +22 | – | – | 7,540 |
| Robert Joseph Toth Jr Director | Dec 31, 2020 | Other | +8 | – | – | 1,230 |
| Anthony Scott Praill Chief Financial Officer | Dec 31, 2020 | Other | +22 | – | – | 7,518 |
| Dennis M. Brown Chief Scientific Officer | Dec 31, 2020 | Other | +17 | – | – | 6,045 |
| Robert Joseph Toth Jr Director | Sep 30, 2020 | Other | +8 | – | – | 1,222 |
| Anthony Scott Praill Chief Financial Officer | Sep 30, 2020 | Other | +22 | – | – | 7,496 |
| Dennis M. Brown Chief Scientific Officer | Sep 30, 2020 | Other | +17 | – | – | 6,028 |
| Keith Murphy Director | Aug 19, 2020 | Buy | +181,010 | – | – | 181,010 |
| John Liatos SVP, Business Development, Director | Aug 19, 2020 | Buy | +196,750 | – | – | 196,750 |
| Dennis M. Brown Chief Scientific Officer | Jun 30, 2020 | Other | +17 | – | – | 6,011 |
| Anthony Scott Praill Chief Financial Officer | Jun 30, 2020 | Other | +22 | – | – | 7,474 |
| Robert Joseph Toth Jr Director | Jun 30, 2020 | Other | +8 | – | – | 1,214 |
| Lynda Sarah Cranston Director | Jun 30, 2020 | Other | −8 | – | – | 332 |
| John K. Bell Director | Jun 30, 2020 | Other | +29 | – | – | 9,817 |
| Anthony Scott Praill Chief Financial Officer | Mar 31, 2020 | Other | +22 | – | – | 7,452 |
| Robert Joseph Toth Jr Director | Mar 31, 2020 | Other | +8 | – | – | 1,206 |
| John K. Bell Director | Mar 31, 2020 | Other | +29 | – | – | 9,788 |
| Dennis M. Brown Chief Scientific Officer | Mar 31, 2020 | Other | +17 | – | – | 5,994 |
| Lynda Sarah Cranston Director | Mar 31, 2020 | Other | −8 | – | – | 324 |
| Lynda Sarah Cranston Director | Dec 31, 2019 | Other | +8 | – | – | 316 |
| Dennis M. Brown Chief Scientific Officer | Dec 31, 2019 | Other | +17 | – | – | 5,977 |
| John K. Bell Director | Dec 31, 2019 | Other | +29 | – | – | 9,759 |
| Robert Joseph Toth Jr Director | Dec 31, 2019 | Other | +8 | – | – | 1,198 |
| Anthony Scott Praill Chief Financial Officer | Dec 31, 2019 | Other | +22 | – | – | 7,430 |
| Dennis M. Brown Chief Scientific Officer | Dec 27, 2019 | Gift | −7,500 | – | – | 5,960 |
| Lynda Sarah Cranston Director | Sep 30, 2019 | Other | +8 | – | – | 308 |
| Robert Joseph Toth Jr Director | Sep 30, 2019 | Other | +8 | – | – | 1,190 |
| John K. Bell Director | Sep 30, 2019 | Other | +29 | – | – | 9,730 |
| Anthony Scott Praill Chief Financial Officer | Sep 30, 2019 | Other | +22 | – | – | 7,408 |
| Dennis M. Brown Chief Scientific Officer | Sep 30, 2019 | Other | +17 | – | – | 13,460 |
| John K. Bell Director | Sep 13, 2019 | Buy | +35,000 | $0.68 | $23.80K | 35,000 |
| John K. Bell Director | Sep 13, 2019 | Buy | +35,000 | $0.68 | $23.80K | 44,701 |
| Robert Joseph Toth Jr Director | Jun 28, 2019 | Other | +8 | – | – | 1,182 |
| John K. Bell Director | Jun 28, 2019 | Other | +29 | – | – | 9,701 |
| Dennis M. Brown Chief Scientific Officer | Jun 28, 2019 | Other | +17 | – | – | 13,443 |
| Anthony Scott Praill Chief Financial Officer | Jun 28, 2019 | Other | +22 | – | – | 7,386 |
| Lynda Sarah Cranston Director | Jun 28, 2019 | Other | +8 | – | – | 300 |
| Lynda Sarah Cranston Director | Mar 29, 2019 | Other | +71 | $0.49 | $35 | 2,912 |
| John K. Bell Director | Mar 29, 2019 | Other | +282 | $0.49 | $138 | 96,711 |
| Dennis M. Brown Chief Scientific Officer | Mar 29, 2019 | Other | +169 | $0.49 | $83 | 134,260 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.